{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:16:33Z","timestamp":1790705793495,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/01.pap.0000249917.96509.e7","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T03:49:54Z","timestamp":1174276194000},"page":"203-212","source":"Crossref","is-referenced-by-count":115,"title":["Oat-derived \u03b2-Glucan Significantly Improves HDLC and Diminishes LDLC and Non-HDL Cholesterol in Overweight Individuals With Mild Hypercholesterolemia"],"prefix":"10.1097","volume":"14","author":[{"given":"Nadia","family":"Reyna-Villasmil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valmore","family":"Berm\u00fadez-Pirela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Mengual-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00edmaco","family":"Cano-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliuz","family":"Leal-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Souki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E","family":"Inglett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar H","family":"Israili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Valasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naikt","family":"Arraiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.metabol.2003.11.008","article-title":"Are major risk factors for myocardial infarction the major predictors of degree of coronary artery disease in men?","volume":"53","author":"Phillips","year":"2004","journal-title":"Metabolism"},{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III).","volume":"285","author":"Cleeman","year":"2001","journal-title":"JAMA"},{"key":"R3-15-20210202","first-page":"379","article-title":"European guidelines on cardiovascular disease prevention in clinical practice. Atherosclerosis. 2003;171:145-155; erratum, Atherosclerosis.","volume":"173","author":"Backer","year":"2004","journal-title":""},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention of coronary heart disease in clinical practice.","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"R5-15-20210202","first-page":"S1","article-title":"Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.","volume":"80","year":"1998","journal-title":"Heart"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial.","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1053\/meta.2002.34695","article-title":"Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B.","volume":"51","author":"Ohmura","year":"2002","journal-title":"Metabolism"},{"key":"R8-15-20210202","first-page":"237","article-title":"New and classical risk factors: the Munster heart study (PROCAM).","volume":"2","author":"Assmann","year":"1997","journal-title":"Eur J Med Res"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1067\/mhj.2003.45","article-title":"High triglycerides\/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease.","volume":"145","author":"Jeppesen","year":"2003","journal-title":"Am Heart J"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol.","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1194\/jlr.M200439-JLR200","article-title":"Impact of simvastatin, niacin, and\/or antioxidants on cholesterol metabolism in CAD patients with low HDL.","volume":"44","author":"Matthan","year":"2003","journal-title":"J Lipid Res"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.102.1.21","article-title":"Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) Study.","volume":"102","author":"Behar","year":"2000","journal-title":"Circulation"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.96.7.2137","article-title":"The Lopid Coronary Angiography Trial (LOCAT) Study Group: prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol.","volume":"96","author":"Frick","year":"1997","journal-title":"Circulation"},{"key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2005.04.002","article-title":"Fibrates and coronary risk reduction Review.","volume":"182","author":"Steiner","year":"2005","journal-title":"Atherosclerosis"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2165\/00003495-200464190-00003","article-title":"Role of fibric acid derivatives in the management of risk factors for coronary heart disease Review.","volume":"64","author":"Despres","year":"2004","journal-title":"Drugs"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/CVM-2-3-118","article-title":"Treating patients with low HDL-cholesterol: choices, issues and opportunities.","volume":"2","author":"Watts","year":"2001","journal-title":"Curr Contr Trials Cardiovasc Med"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1194\/jlr.M200037-JLR200","article-title":"Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients.","volume":"43","author":"Asztalos","year":"2002","journal-title":"J Lipid Res"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systemic review Review.","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"key":"R21-15-20210202","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.281.21.1998","article-title":"Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.","volume":"281","author":"Wolk","year":"1999","journal-title":"JAMA"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/69.1.30","article-title":"Cholesterol-lowering effects of dietary fiber: a meta-analysis.","volume":"69","author":"Brown","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ajcn\/75.5.834","article-title":"Soluble fiber intake at a dose approved by US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial.","volume":"75","author":"Jenkins","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(63)90210-1","article-title":"Cholesterol lowering effect of rolled oats.","volume":"2","author":"De Groot","year":"1963","journal-title":"Lancet"},{"key":"R25-15-20210202","first-page":"260","article-title":"Can dietary oats promote health?","volume":"51","author":"Welch","year":"1994","journal-title":"Br J Biomed Sci"},{"key":"R26-15-20210202","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1001\/jama.1992.03480240079039","article-title":"Oat products and lipid lowering: a meta-analysis.","volume":"267","author":"Ripsin","year":"1992","journal-title":"JAMA"},{"key":"R27-15-20210202","first-page":"465","article-title":"Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.","volume":"48","author":"Braaten","year":"1994","journal-title":"Eur J Clin Nutr"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ajcn\/78.2.221","article-title":"Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies.","volume":"78","author":"Kerckhoffs","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/07315724.1997.10718648","article-title":"Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women.","volume":"16","author":"Behall","year":"1997","journal-title":"J Am Coll Nutr"},{"key":"R30-15-20210202","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ajcn.83.3.601","article-title":"Beta-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations.","volume":"83","author":"Naumann","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R31-15-20210202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jada.2005.03.006","article-title":"Cholesterol-lowering benefits of oat-containing cereal in Hispanic Americans.","volume":"105","author":"Karmally","year":"2005","journal-title":"J Am Diet Assoc"},{"key":"R32-15-20210202","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/07315724.1992.10718264","article-title":"A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein.","volume":"11","author":"Uusitupa","year":"1992","journal-title":"J Am Coll Nutr"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/jama.1991.03460140061027","article-title":"The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study.","volume":"265","author":"Davidson","year":"1991","journal-title":"JAMA"},{"key":"R34-15-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1753-4887.1991.tb03021.x","article-title":"Soluble fiber polysaccharides: effects on plasma cholesterol and colonic fermentation.","volume":"49","author":"Topping","year":"1991","journal-title":"Nutr Rev"},{"key":"R35-15-20210202","first-page":"296","article-title":"Food labeling: health claims: oats and coronary heart disease.","volume":"61","year":"1996","journal-title":"Fed Regist"},{"key":"R36-15-20210202","first-page":"44207","article-title":"Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Final rule.","volume":"68","author":"Food and Drug Administration","year":"2003","journal-title":"Fed Regist"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ajcn\/69.1.55","article-title":"Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with -glucan.","volume":"69","author":"Bourdon","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"R38-15-20210202","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0278-6915(03)00046-2","article-title":"Repeated dose oral toxicological evaluation of concentrated barley beta-glucan in CD-1 mice including a recovery phase.","volume":"41","author":"Delaney","year":"2003","journal-title":"Food Chem Toxicol"},{"key":"R39-15-20210202","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ajcn.70.2.208","article-title":"Plasma lipid changes after supplementation with beta-glucan fiber from yeast.","volume":"70","author":"Nicolosi","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"R40-15-20210202","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1517\/14712598.5.5.691","article-title":"Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer.","volume":"5","author":"Yan","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"R41-15-20210202","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/diacare.19.11.1294","article-title":"Fat replacers: their use in foods and role in diabetes medical nutrition therapy.","volume":"19","author":"Warshaw","year":"2000","journal-title":"Diabetes Care"},{"key":"R42-15-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.0950-5423.2003.00750.x","article-title":"Use of a -glucan hydrocolloidal suspension in the manufacture of low-fat cheddar cheeses: manufacture, composition, yield and microstructure.","volume":"39","author":"Konuklar","year":"2004","journal-title":"Int J Food Sci Tech"},{"key":"R43-15-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.foodhyd.2003.08.010","article-title":"Use of -glucan hydrocolloidal suspension in the manufacture of low-fat cheddar cheeses: textural properties by instrumental methods and sensory panels.","volume":"18","author":"Konuklar","year":"2004","journal-title":"Food Hydrocoll"},{"key":"R44-15-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1094\/CCHEM.2004.81.5.637","article-title":"Effect of Nutrim oat bran and flaxseed on rheological properties of cakes.","volume":"81","author":"Lee","year":"2004","journal-title":"Cereal Chem"},{"key":"R45-15-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.foodchem.2003.08.023","article-title":"Rheological, textural, and sensory properties of Asian noodles containing an oat cereal hydrocolloid.","volume":"90","author":"Inglett","year":"2005","journal-title":"Food Chem"},{"key":"R46-15-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0278-6915(02)00298-3","article-title":"Evaluation of the toxicity of concentrated barley beta-glucan in a 28-day feeding study in Wistar rats.","volume":"41","author":"Delaney","year":"2003","journal-title":"Food Chem Toxicol"},{"key":"R47-15-20210202","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R48-15-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ajcn\/61.2.379","article-title":"Diets containing soluble oat extracts improve glucose and insulin responses of moderately hypercholesterolemic men and women.","volume":"61","author":"Hallfrisch","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"R49-15-20210202","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.2337\/diacare.27.2007.S36","article-title":"American Diabetes Association Position Statements: nutrition principles and recommendations in diabetes.","volume":"27","author":"Franz","year":"2004","journal-title":"Diabetes Care"},{"key":"R51-15-20210202","first-page":"40","article-title":"Sensory assessment of food texture.","volume":"26","author":"Abbott","year":"1972","journal-title":"Food Technol"},{"key":"R52-15-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00001573-200307000-00008","article-title":"Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes.","volume":"18","author":"Viles-Gonzalez","year":"2003","journal-title":"Curr Opin Cardiol"},{"key":"R53-15-20210202","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1185\/030079905X74952","article-title":"LDL-C\/HDL-C ratio in subjects with cardiovascular disease and a low LDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different dosages and reverse cholesterol transport) study.","volume":"21","author":"Jukema","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R54-15-20210202","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","article-title":"Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.","volume":"161","author":"Cui","year":"2001","journal-title":"Arch Intern Med"},{"issue":"Suppl A","key":"R55-15-20210202","doi-asserted-by":"crossref","first-page":"A43","DOI":"10.1016\/j.ehjsup.2004.01.010","article-title":"Non-high-density lipoprotein cholesterol as a risk factor: addressing risk associated with apolipoprotein B-containing lipoproteins.","volume":"6","author":"Chapman","year":"2004","journal-title":"Eur Heart J"},{"key":"R57-15-20210202","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/euhj.2000.2402","article-title":"Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE study. Finland, Italy, Netherlands, Elderly.","volume":"22","author":"Menotti","year":"2001","journal-title":"Eur Heart J"},{"key":"R58-15-20210202","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00125-003-1141-5","article-title":"A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism: the Hoorn Study.","volume":"46","author":"Bos","year":"2003","journal-title":"Diabetologia"},{"key":"R59-15-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-2275(20)39173-2","article-title":"Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.","volume":"35","author":"Schaefer","year":"1994","journal-title":"J Lipid Res"},{"key":"R60-15-20210202","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ajcn\/78.4.711","article-title":"Randomized controlled crossover study of the effect of a highly -glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men.","volume":"78","author":"Keogh","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R61-15-20210202","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/hq0701.092137","article-title":"Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study.","volume":"21","author":"Couillard","year":"2001","journal-title":"Arterioscl Thromb Vascular Biol"},{"key":"R62-15-20210202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/ajcn\/82.5.957","article-title":"Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol.","volume":"82","author":"Lefevre","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"R63-15-20210202","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/80.5.1185","article-title":"Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women.","volume":"80","author":"Behall","year":"2004","journal-title":"Am J Clim Nutr"},{"key":"R64-15-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000012798","article-title":"Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia.","volume":"43","author":"Onning","year":"1999","journal-title":"Ann Nutr Metab"},{"key":"R65-15-20210202","first-page":"517","article-title":"Effects of oat gum on blood cholesterol levels in healthy young men.","volume":"49","author":"Beer","year":"1995","journal-title":"Eur J Clin Nutr"},{"key":"R66-15-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01091229","article-title":"Oat beta-glucan-amylodextrins: preliminary preparations and biological properties.","volume":"45","author":"Inglett","year":"1994","journal-title":"Plant Foods Hum Nutr"},{"key":"R67-15-20210202","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0002-8223(96)00329-X","article-title":"Oat bran concentrate bread products improve long-term control of diabetes: a pilot study.","volume":"96","author":"Pick","year":"1996","journal-title":"J Am Dietetic Assoc"},{"key":"R68-15-20210202","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/jf040322c","article-title":"Content and molecular weight of extractable beta-glucan in American and Swedish oat samples.","volume":"53","author":"Ajithkumar","year":"2005","journal-title":"J Am Agri Food Chem"},{"key":"R69-15-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3177\/jnsv.49.381","article-title":"Barley beta-glucan lowers serum cholesterol based on the up-regulation of cholesterol 7alpha-hydroxylase activity and mRNA abundance in cholesterol-fed rats.","volume":"49","author":"Yang","year":"2003","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"R70-15-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/ajcn\/76.5.1111","article-title":"Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one.","volume":"76","author":"Andersson","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R71-15-20210202","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/ajcn\/62.6.1245","article-title":"Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects.","volume":"62","author":"Lia","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"R72-15-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1079\/BJN19890010","article-title":"Effect of oat gum on the physical properties of the gastrointestinal contents and on the uptake of D-galactose and cholesterol by rat small intestine in vitro.","volume":"62","author":"Lund","year":"1989","journal-title":"Br J Nutr"},{"key":"R73-15-20210202","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2337\/diacare.20.11.1774","article-title":"The role of viscous soluble fiber in the metabolic control of diabetes: a review with special emphasis on cereals rich in beta-glucan.","volume":"20","author":"Wursch","year":"1997","journal-title":"Diabetes Care"},{"key":"R74-15-20210202","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/0929867003374705","article-title":"Immunomodulation and anti-cancer activity of polysaccharide-protein complexes.","volume":"7","author":"Ooi","year":"2000","journal-title":"Curr Med Chem"},{"key":"R75-15-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ajcn\/72.1.49","article-title":"Modest doses of -glucan do not reduce concentrations of potentially atherogenic lipoproteins.","volume":"72","author":"Lovegrove","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"R76-15-20210202","first-page":"369","article-title":"Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial.","volume":"51","author":"Keenan","year":"2002","journal-title":"J Fam Prac"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.pap.0000249917.96509.e7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:34:58Z","timestamp":1786034098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200703000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pap.0000249917.96509.e7","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}